Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: J Clin Lipidol. 2013 Feb 26;7(3):187–193. doi: 10.1016/j.jacl.2013.02.002

Table I.

Criteria for inclusion and exclusion of study participants.

Inclusion Criteria Exclusion Criteria

  • Males and females over age 20 years

  • Prior history of statin myalgia

    Criteria:

    1. Patient developed new myalgia, cramps, or muscle aching during statin treatment and,

    2. Symptoms resolved within 4 weeks of stopping the statin

  • Willing to limit alcohol intake to two or less drinks daily

  • Cancer within 5 years of entry

  • Hepatic disease (ALT* > 2 times normal)

  • Renal disease (creatinine > 2 mg/L)

  • Hypo- or hyperthyroidism (TSH* > 5 or < 0.01 IU/L)

  • Taking any medications known to alter statin metabolism

  • Cannot discontinue other lipid-lowering medications

  • Regular use of corticosteroids or other drugs known to affect skeletal muscle

  • Receiving intramuscular injections that affect CK* levels

  • Physical disability preventing strength and exercise performance measurements

  • Women of child-bearing age who are not using an effective birth control technique

  • History of severe rhabdomyolysis (CK > 10 UNL*)

*

Abbreviations : ALT: alanine aminotransferase; CK: creatine kinase; TSH: thyroid stimulating hormone; UNL: upper normal limit